Determinants of cervical cancer screening among women living with HIV in Zimbabwe.
Roger AntabeNasong A LuginaahJoseph KangmennaangPaul MkandawirePublished in: Health promotion international (2023)
In sub-Saharan Africa (SSA), cervical cancer (CC) is the second leading cause of cancer-related deaths, with human immunodeficiency virus (HIV) seropositive women being particularly vulnerable. Despite the benefits of early CC screening in reducing HIV-related CC deaths, CC screening uptake remains limited, with wide disparities in access across SSA. As part of a larger study, this paper examines the determinants of CC screening among HIV-seropositive women of reproductive age (15-49 years) in Zimbabwe. Using the 2015 Zimbabwe Demographic and Health Survey, we conducted multilevel analyses of CC screening among 1490 HIV-seropositive women, nested in 400 clusters. Our findings revealed that, even though 74% of HIV-seropositive women knew about CC, only 17.6% of them reported ever screening for it. Women who held misconceptions about HIV (OR = 0.47, p = 0.01) were less likely to screen for CC compared to those with accurate knowledge about HIV and CC. HIV-seropositive women with secondary or higher education were more likely to screen (OR = 1.39, p = 0.04) for CC compared to those with a primary or lower level of education. Age was positively associated with screening for CC. Furthermore, locational factors, including province and rural-urban residence, were associated with CC screening. Based on these findings, we call for integrated care and management of HIV and non-communicable diseases in Southern Africa, specifically, Zimbabwe due to the legacy of HIV in the region.
Keyphrases
- human immunodeficiency virus
- antiretroviral therapy
- hiv testing
- hiv positive
- hiv infected
- hepatitis c virus
- men who have sex with men
- hiv aids
- cervical cancer screening
- polycystic ovary syndrome
- healthcare
- south africa
- palliative care
- quality improvement
- breast cancer risk
- chronic pain
- health insurance
- adipose tissue
- mass spectrometry